CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors
Conditions: B-NHL, Extranodal, TP53 Alterations, Bulky Mass Interventions: Biological: autologous stem-cell transplantation, Relmacabtagene autoleucel (relma-cel) Sponsors: Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation
Conditions: Kidney Transplantation Interventions: Biological: TCD601; Drug: Tacrolimus (TAC); Drug: Corticosteroids (CS); Drug: Mycophenolate Mofetil (MMF); Drug: ATG Sponsors: ITB-Med LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Liver Transplantation for Hepatocellular Carcinoma Arising in Non-cirrhotic Liver: a Propensity Score-matched Retrospective Cohort Study of Two National Databases
Conditions: Hepatocellular Carcinoma, Non-cirrhotic Liver Interventions: Other Sponsors: Xiao Xu Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Prevalence of CYP3A5 Polymorphisms in the Donors and ABCB1 Polymorphisms in the Recipients Undergoing Pediatric Liver Transplant and Their Influence on Tacrolimus Levels and Graft Function.
Conditions: Pediatric Liver Transplant Interventions: Other: No intervention Sponsors: Institute of Liver and Biliary Sciences, India Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen
Conditions: CMV Infection or Reactivation After Allogenic HSCT Sponsors: Siriraj Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Fatigue and Cognitive Dysfunction After Allogeneic Stemcell Transplantation, Prospective PET Study
Conditions: Fatigue; Cognitive Dysfunction Sponsors: Karolinska Institutet; Karolinska University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Spanish BMT4me Usability & Acceptability
Conditions: Bone Marrow Transplant Interventions: Other: BMT4me Sponsors: Nationwide Children ' s Hospital; Columbia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage
Conditions: Intracerebral Hemorrhage Interventions: Drug: HUFF-01 Sponsors: Hokkaido University Hospital; Japan Agency for Medical Research and Development Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Split or Whole Liver Transplantation? A Multicenter Retrospective Cohort Study of Patients With Benign and Malignant Liver Disease
Conditions: Zhejiang University Interventions: Other: No intervention factor Sponsors: Zhejiang University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Platelet Count and Function After Usage of Two Different Cell Saver Devices During Liver Transplant Surgery
Conditions: Liver Transplant; Hemorrhage, Surgical Interventions: Device: Cell Salvage Autotransfusion: SAME ™ device; Device: Cell Salvage Autotransfusion: Autolog™ device Sponsors: Eduardo Schiffer; University Hospital, Geneva; Insel Gruppe AG, University Hospital Bern Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell AntibodY
Conditions: Sickle Cell Disease Interventions: Drug: Daratumumab; Drug: Alemtuzumab; Drug: Sirolimus; Radiation: Total Body Irradiation Sponsors: Children ' s National Research Institute; Alberta Children ' s Hospital; The Hospital for Sick Children; Levine Children ' s Hospital; Ann& Robert H Lurie Children ' s Hospital of Chicago; Nationwide Children ' s Hospital; Children ' s Hospital at Montefiore; Doris Duke Charitable Foundation; Janssen Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
the Intensive Care Unit Diary for Liver Transplant Recipients
Conditions: Liver Transplant Disorder Interventions: Behavioral: intensive care unit diary Sponsors: Chang Gung Memorial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
Conditions: Acute Lymphoblastic Leukaemia; Acute Leukemia of Ambiguous Lineage; Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Acute Myeloid Leukemia Interventions: Drug: EBX-102; Drug: Placebo Sponsors: Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
Conditions: Liver Transplantation; Immunosuppression Interventions: Drug: XR-tacrolimus QD + MMF BID; Drug: LCP-tacrolimus QD + MMF BID; Drug: LCP-tacrolimus QD + MMF QD Sponsors: University Hospital, Limoges Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection
Conditions: Kidney Transplant Patients Eligible for a Solid Biopsy Sponsors: Assistance Publique - H ôpitaux de Paris; CGenetix; Institut National de la Santé Et de la Recherche Médicale, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
